Solutions

Health Partners

PolyCypher Health’s AI-driven platform is designed for large, health-related enterprises and their members:

For enterprises, the platform provides population-level analytics regarding the health of the member base
For members, the platform prevents common diseases like cancer, heart disease, etc. through disease-risk prediction and reduction
Target sectors include digital health, health systems, primary care, employers, and others

Life Sciences

PolyCypher Health’s AI-driven platform accelerates biopharma and medical research and development by:

Clinical trial optimization through more effective participant selection
Development of companion diagnostics for biopharma and medical devices
Novel target discovery for new therapeutics
Advanced research into disease mechanisms through integrated genomic and health data

Biomarkers
Originally used in the field of Oncology to predict the recurrence of cancer.
Clinical Insight
Uses similar biomarkers to predict common clinical disorders in everyday life. For instance, blood cholesterol is a well-known biomarker of risk for coronary heart disease, and prostate-specific antigen (PSA) is a biomarker associated with prostate cancer.
Polygenic Risk Scores
A measure of an individual’s aggregate genetic risk for a disease, based on multiple common, low-risk variants across the genome that are associated with the disease.
Predictive Prevention
Risk scoring is predictive and addresses the broad range of common diseases. In contrast to traditional monogenic testing for rare mutations carried by less than 2% of the population, our polygenic risk scores deal with common mutations, so they apply broadly across the population.

The Science Behind Smarter Health Decisions

From traditional biomarkers to advanced polygenic insights, we combine the best of science to predict risk earlier and guide better decisions.

PolyCypher Health’s AI-driven platform translates complex biology into actionable medical insights!

Disease risk prediction

Our proprietary bioinformatics pipeline determines polygenic risk scores for a broad range of common diseases and cancers, including: coronary artery disease, atrial fibrillation, stroke, Alzheimer’s disease, Type-2 diabetes, and various cancers.

Personalized reports

Patient and physician receive personalized reports of disease risks for tailored preventive guidance, enabling early intervention and lifestyle modifications to mitigate risk factors.

Electronic health records analytics

Our platform performs electronic phenotyping to discover and understand cohorts of interest and integrates this information with polygenic data for comprehensive disease risk assessment.

Risk tracking

We track risk changes over time and support risk reduction efforts. Our platform can integrate with behavioral change platforms and other health interventions to maximize effectiveness.

HIPAA compliance and security

All data is stored in HIPAA compliant databases, designed for scalability and long-term use in machine learning projects, ensuring both security and continued improvement.

Continuous learning

Our platform becomes more intelligent over time as more data is analyzed, improving predictive accuracy and enabling more effective preventive interventions.